{"id":35865,"date":"2026-09-15T06:11:00","date_gmt":"2026-09-15T06:11:00","guid":{"rendered":"https:\/\/egeajans.ege.edu.tr\/?p=35865"},"modified":"2026-09-15T07:28:11","modified_gmt":"2026-09-15T07:28:11","slug":"prof-dr-sahin-lenfoma-tedavi-edilebilir-bir-hastaliktir","status":"publish","type":"post","link":"https:\/\/egeajans.ege.edu.tr\/index.php\/2026\/09\/15\/prof-dr-sahin-lenfoma-tedavi-edilebilir-bir-hastaliktir\/","title":{"rendered":"Prof. Dr. \u015eahin, \u201cLenfoma tedavi edilebilir bir hastal\u0131kt\u0131r\u201d"},"content":{"rendered":"<p style=\"text-align: justify;\">15 Eyl\u00fcl D\u00fcnya Lenfoma Fark\u0131ndal\u0131k G\u00fcn\u00fc<\/p>\n<p style=\"text-align: justify;\">Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi Hematoloji Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Prof. Dr. Fahri \u015eahin, lenfoman\u0131n belirtileri, tan\u0131 s\u00fcre\u00e7leri ve tedavi y\u00f6ntemleri hakk\u0131nda \u00f6nemli a\u00e7\u0131klamalarda bulundu. Prof. Dr. \u015eahin, erken te\u015fhis edilirse lenfoman\u0131n g\u00fcncel tedavi y\u00f6ntemleriyle tedavi edilebilir bir hastal\u0131k oldu\u011funu vurgulad\u0131.<\/p>\n<p style=\"text-align: justify;\">Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi \u0130\u00e7 Hastal\u0131klar\u0131 Anabilim Dal\u0131, Hematoloji Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Prof. Dr. Fahri \u015eahin, \u201c15 Eyl\u00fcl D\u00fcnya Lenfoma Fark\u0131ndal\u0131k G\u00fcn\u00fc\u201d dolay\u0131s\u0131yla toplumda bilin\u00e7 olu\u015fturmak amac\u0131yla \u00f6nemli a\u00e7\u0131klamalarda bulundu. Lenfoman\u0131n korkulacak bir hastal\u0131k olmad\u0131\u011f\u0131n\u0131, aksine do\u011fru tan\u0131 ve tedaviyle ba\u015far\u0131yla y\u00f6netilebilece\u011fini vurgulayan Prof. Dr. \u015eahin, belirtiler konusunda bilin\u00e7li olman\u0131n \u00f6nemine de\u011findi.<\/p>\n<p style=\"text-align: justify;\">Her lenf bezi b\u00fcy\u00fcmesinin lenfoma olmad\u0131\u011f\u0131n\u0131 hat\u0131rlatan Prof. Dr. Fahri \u015eahin, \u201cLenf bezleri, ba\u011f\u0131\u015f\u0131kl\u0131k sistemimizin en \u00f6nemli organlar\u0131ndan olup ba\u015fl\u0131ca g\u00f6revleri enfeksiyonlara kar\u015f\u0131 sava\u015fmakt\u0131r. Lenf bezleri v\u00fccudumuzda kulak arkas\u0131 ve \u00f6n\u00fc, \u00e7ene alt\u0131, boyun k\u0131sm\u0131, koltuk alt\u0131, kas\u0131k b\u00f6lgesi ba\u015fta olmak \u00fczere yayg\u0131n olarak da\u011f\u0131lm\u0131\u015f durumdad\u0131r. Enfeksiyonlar, abse, a\u015f\u0131 reaksiyonu, bazen bir ila\u00e7, baz\u0131 romatolojik hastal\u0131klar gibi durumlar lenf bezlerini b\u00fcy\u00fctebilirken lenfomalar, l\u00f6semiler ve bir kanserin metastaz\u0131 da lenf bezlerinin b\u00fcy\u00fcmesine sebep olabilir. Lenf bezi b\u00fcy\u00fcmesine neden olan hematolojik hastal\u0131klar\u0131n ba\u015f\u0131nda gelen Lenfoma, genel olarak Hodgkin ve Hodgkin d\u0131\u015f\u0131 (Non-Hodgkin) lenfoma olarak iki gruba ayr\u0131l\u0131r. Bu ana ba\u015fl\u0131klar\u0131n ayr\u0131ca onlarca de\u011fi\u015fik alt tipi mevcuttur\u201d dedi.<\/p>\n<p style=\"text-align: justify;\"><strong>Gece terlemesi ve istemsiz kilo kayb\u0131 gibi belirtiler \u00f6nemli<\/strong><\/p>\n<p style=\"text-align: justify;\">Hastal\u0131\u011f\u0131n en s\u0131k g\u00f6r\u00fclen belirtisinin boyun, koltuk alt\u0131 veya kas\u0131k b\u00f6lgesindeki a\u011fr\u0131s\u0131z \u015fi\u015flikler oldu\u011funu ifade eden Prof. Dr. \u015eahin, \u201cLenfoma, ba\u011f\u0131\u015f\u0131kl\u0131k sistemimizin \u00f6nemli h\u00fccrelerinden olan lenfositlerin kontrols\u00fcz \u00e7o\u011falmas\u0131yla geli\u015fen ve \u00e7o\u011funlukla lenf bezlerinde yerle\u015fen bir kanser t\u00fcr\u00fcd\u00fcr. Lenf bezleri d\u0131\u015f\u0131nda kemik ili\u011fi, dalak ve di\u011fer lenf dokular\u0131nda da bulunabilirler. Lenfoman\u0131n en s\u0131k fark edilen bulgular\u0131ndan biri boyun, koltuk alt\u0131 veya kas\u0131k b\u00f6lgesinde a\u011fr\u0131s\u0131z lenf bezi b\u00fcy\u00fcmesidir. Ancak tekrar belirtelim ki her lenf bezi b\u00fcy\u00fcmesi lenfoma anlam\u0131na gelmez. \u00d6zellikle enfeksiyonlar lenf bezlerinin b\u00fcy\u00fcmesine sebep olan en s\u0131k durumdur. Baz\u0131 hastalarda lenfoma uzun s\u00fcre herhangi bir belirti vermeyebilir. Lenf bezi b\u00fcy\u00fcmesine e\u015flik eden \u015fu bulgu ve belirtiler varl\u0131\u011f\u0131nda mutlaka bir sa\u011fl\u0131k kurulu\u015funa veya hekime ba\u015fvurmak gerekir. Nedeni a\u00e7\u0131klanamayan, \u00f6zellikle ak\u015famlar\u0131 y\u00fckselen ve uzun s\u00fcren ate\u015f; \u00f6zellikle geceleri k\u0131yafet veya \u00e7ar\u015faf de\u011fi\u015ftirecek kadar yo\u011fun terleme, istemsiz kilo kayb\u0131, s\u00fcregelen halsizlik ve yorgunluk, kar\u0131nda \u015fi\u015fkinlik veya erken doyma, \u00f6ks\u00fcr\u00fck, nefes darl\u0131\u011f\u0131 veya g\u00f6\u011f\u00fcste bask\u0131 hissi, yayg\u0131n ka\u015f\u0131nt\u0131. \u00d6zellikle nedeni a\u00e7\u0131klanamayan, kal\u0131c\u0131 veya giderek b\u00fcy\u00fcyen bir lenf bezi, beraberinde ate\u015f, gece terlemesi ya da istemsiz kilo kayb\u0131 gibi bulgular varsa mutlaka bir hematoloji uzman\u0131 taraf\u0131ndan de\u011ferlendirilmelidir\u201d diye konu\u015ftu.<\/p>\n<p style=\"text-align: justify;\"><strong>Tan\u0131da alt\u0131n standart: Biyopsi<\/strong><\/p>\n<p style=\"text-align: justify;\">Tan\u0131 s\u00fcrecinin sadece hastan\u0131n \u00f6yk\u00fcs\u00fc, kan tahlili veya g\u00f6r\u00fcnt\u00fcleme y\u00f6ntemleriyle tamamlanamayaca\u011f\u0131n\u0131 vurgulayan Prof. Dr. \u015eahin, kesin tan\u0131 i\u00e7in hastal\u0131kl\u0131 dokudan biyopsi al\u0131nmas\u0131n\u0131n \u015fart oldu\u011funu belirtti. Prof. \u015eahin, \u201cAl\u0131nan dokunun patolojik incelemesiyle lenfoman\u0131n tam tipi belirlenir. Bu ayr\u0131m kritik bir \u00f6neme sahiptir; \u00e7\u00fcnk\u00fc tedavi plan\u0131 tamamen lenfoman\u0131n alt tipine g\u00f6re \u015fekillenir. Tan\u0131n\u0131n ard\u0131ndan PET-BT ve kemik ili\u011fi biyopsisi gibi tetkiklerle hastal\u0131\u011f\u0131n evrelemesi yap\u0131l\u0131r. Hastal\u0131\u011f\u0131n tipi, evresi ve ki\u015finin genel sa\u011fl\u0131k durumu tedavi plan\u0131n\u0131n belirlenmesinde birlikte de\u011ferlendirilir\u201d dedi.<\/p>\n<p style=\"text-align: justify;\"><strong>Lenfoma ya\u015fam\u0131 nas\u0131l etkiler?<\/strong><\/p>\n<p style=\"text-align: justify;\">Tedavi d\u00f6neminde lenfoman\u0131n ya\u015fam standartlar\u0131n\u0131 etkileme s\u00fcre\u00e7lerinden bahseden Prof. Dr. \u015eahin, \u201cLenfoma tan\u0131s\u0131 ki\u015finin yaln\u0131zca fiziksel sa\u011fl\u0131\u011f\u0131n\u0131 de\u011fil, duygusal ve sosyal ya\u015fam\u0131n\u0131 da etkileyebilir. Tan\u0131 sonras\u0131nda kayg\u0131, belirsizlik ve gelecek endi\u015fesi ya\u015fanmas\u0131 olduk\u00e7a do\u011fald\u0131r. Tedavi d\u00f6neminde yorgunluk, enfeksiyonlara yatk\u0131nl\u0131k, bulant\u0131, i\u015ftah de\u011fi\u015fiklikleri, sa\u00e7 d\u00f6k\u00fclmesi veya tedaviye ba\u011fl\u0131 di\u011fer yan etkiler g\u00f6r\u00fclebilir. Ancak bu etkiler hastadan hastaya de\u011fi\u015fir ve g\u00fcn\u00fcm\u00fczde yan etkilerin \u00f6nlenmesi veya azalt\u0131lmas\u0131 i\u00e7in \u00e7ok say\u0131da destek tedavisi bulunmaktad\u0131r. Tedavi tamamland\u0131ktan sonra da d\u00fczenli kontroller \u00f6nemlidir. Pek \u00e7ok ki\u015fi tedavisini tamamlayarak i\u015fine, okuluna, sosyal ya\u015fam\u0131na ve g\u00fcnl\u00fck aktivitelerine geri d\u00f6nebilir. Hastal\u0131\u011f\u0131n seyri ve tedavi s\u00fcreci ki\u015fisel oldu\u011fu i\u00e7in ya\u015fam plan\u0131 da hastaya \u00f6zel olarak olu\u015fturulmal\u0131d\u0131r\u201d diye konu\u015ftu.<\/p>\n<p style=\"text-align: justify;\"><strong>Ak\u0131ll\u0131 ila\u00e7lar ve yeni nesil tedaviler umut veriyor<\/strong><\/p>\n<p style=\"text-align: justify;\">Lenfoman\u0131n tedavi ba\u015far\u0131s\u0131 en y\u00fcksek kanser t\u00fcrlerinden biri oldu\u011funun alt\u0131n\u0131 \u00e7izen Prof. Dr. \u015eahin, \u201cBir\u00e7ok lenfoma t\u00fcr\u00fcnde tamamen iyile\u015fme m\u00fcmk\u00fcnd\u00fcr. Tedavide kemoterapinin yan\u0131 s\u0131ra ba\u011f\u0131\u015f\u0131kl\u0131k sistemini hedefleyen imm\u00fcnoterapiler, halk aras\u0131nda \u2018ak\u0131ll\u0131 ila\u00e7\u2019 olarak bilinen hedefe y\u00f6nelik tedaviler, radyoterapi ve uygun vakalarda k\u00f6k h\u00fccre nakli kullan\u0131lmaktad\u0131r. Son y\u0131llardaki teknolojik geli\u015fmeler ve yeni nesil ila\u00e7lar sayesinde art\u0131k daha fazla hastam\u0131z\u0131n hayat\u0131na dokunabiliyor, iyile\u015fme oranlar\u0131n\u0131 art\u0131rabiliyoruz\u201d dedi.<\/p>\n<p style=\"text-align: justify;\">Prof. Dr. Fahri \u015eahin, lenfoma i\u00e7in standart bir tarama testi olmad\u0131\u011f\u0131n\u0131 hat\u0131rlatarak, v\u00fccuttaki de\u011fi\u015fiklikleri fark etmenin ve erken evrede tedaviye ba\u015flaman\u0131n en \u00f6nemli fakt\u00f6r oldu\u011funu belirtti. Prof. Dr. \u015eahin, \u201cHi\u00e7bir hasta bu yolculukta yaln\u0131z de\u011fildir. Erken te\u015fhis, daha az yan etki ve daha y\u00fcksek ba\u015far\u0131 demektir. Unutmay\u0131n; en de\u011ferli varl\u0131\u011f\u0131m\u0131z, sa\u011fl\u0131\u011f\u0131m\u0131zd\u0131r\u201d diyerek s\u00f6zlerini noktalad\u0131.<\/p>\n<p style=\"text-align: justify;\">\n<p style=\"text-align: justify;\">\n","protected":false},"excerpt":{"rendered":"<p>15 Eyl\u00fcl D\u00fcnya Lenfoma Fark\u0131ndal\u0131k G\u00fcn\u00fc Ege \u00dcniversitesi T\u0131p Fak\u00fcltesi Hematoloji Bilim Dal\u0131 \u00d6\u011fretim \u00dcyesi Prof. Dr. Fahri \u015eahin, lenfoman\u0131n belirtileri, tan\u0131 s\u00fcre\u00e7leri ve tedavi y\u00f6ntemleri hakk\u0131nda \u00f6nemli a\u00e7\u0131klamalarda bulundu.&hellip;<\/p>\n","protected":false},"author":2,"featured_media":35869,"comment_status":"closed","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,11,70,68],"tags":[],"class_list":["post-35865","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gncl","category-haber","category-kampus","category-saglik"],"_links":{"self":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/35865","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/comments?post=35865"}],"version-history":[{"count":1,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/35865\/revisions"}],"predecessor-version":[{"id":35867,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/posts\/35865\/revisions\/35867"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/media\/35869"}],"wp:attachment":[{"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/media?parent=35865"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/categories?post=35865"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/egeajans.ege.edu.tr\/index.php\/wp-json\/wp\/v2\/tags?post=35865"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}